Leqvio (inclisiran)
pCPA File Number:
22674
Negotiation Status:
Negotiations were not pursued
Indication(s):
Primary hypercholesterolemia (non-familial and heterozygous familial) with atherosclerotic cardiovascular disease
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0791-001
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: